Besides the cytoskeleton, ELK1 has also been found to affect tumor microenvironment in PaCa, through modulation of the cysteine protease Legumain (LGMN) [274]. This evidence concerns the gene ELK1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.